APA citiranje

Mimura, N., Fulciniti, M., Gorgun, G., Tai, Y., Cirstea, D., Santo, L., . . . Anderson, K. C. (2012). Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma. American Society of Hematology.

Citação norma Chicago

Mimura, Naoya, et al. Blockade of XBP1 Splicing By Inhibition of IRE1α Is a Promising Therapeutic Option in Multiple Myeloma. American Society of Hematology, 2012.

MLA citiranje

Mimura, Naoya, et al. Blockade of XBP1 Splicing By Inhibition of IRE1α Is a Promising Therapeutic Option in Multiple Myeloma. American Society of Hematology, 2012.